Educational Qualification

• Postdoctoral Researcher, The University of West Indies, Trinidad (2006-2008) 
• Ph.D.:  Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (2006)
• M. Pharm.: (Pharmaceutical Chemistry), Karnatak University, Dharwad, India (1997)
• Bachelor of Pharmacy: RTM Nagpur University, Nagpur, India (1995)  

Professional Career

• Professor and Chairperson, Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2019 till date)  
• Chairperson in-charge, Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (September 2017 to May 2019).  
• Associate Professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2014 to May 2019)   
• Assistant professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (Nov 2010 to May 2014)  
• Lecturer in Pharmaceutical Chemistry, School of Pharmacy and Health Sciences, International Medical University, Kuala Lumpur, Malaysia (Aug 2008- Nov 2010) 
• Postdoctoral Researcher, Department of Chemistry, The University of West Indies, Trindad, (Nov 2006- June 2008)
• Assistant Professor, Institute of Pharmaceutical Education & Research, Wardha, India (Oct 2005-August 2006) 
• Lecturer in Pharmaceutical Chemistry, Anuradha College of Pharmacy, Chikhli, MS, India (Jan 1998-Jan 2001) 
• Senior Research Fellow, The Council of Scientific and Industrial Research (CSIR), Ministry of Science & Technology, Government of India at KLE College of Pharmacy, Belgaum, India (Jan 2002-04) 

Achievements/ Interests/Publications/Awards

Patents: 

• Bhoomendra A. Bhongade, Sirajunisa Talath, Chiral imidazo[2,1-b][1,3,4]thiadiazole compounds and processes for synthesizing the same. Indian Patent 373257, July 29, 2021.
• G. Singh, P.J. Plaza, B. A. Bhongade. Synthesis and use of chiral ionic liquids. United States Patent, US8,788,689 B1, July 15, 2014.

Review Reports/Articles: 

• Balaji Venkataraman, Shreesh Ojha, Prasanna D. Belur, Bhoomendra Bhongade, Vishnu Raj, Peter D. Collin, Thomas E. Adrian, Sandeep B. Subramanya. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases. Phytotherapy Research. 2020;1–20. 
• B. A. Bhongade, S. Talath, R. A. Gadad, A. K. Gadad, Biological Activities of Imidazo[2,1-b][1,3,4]thiadiazole Derivatives: A Review. J. Saudi Chem. Soc. 2016, 20(S1), S463-S475. 
• Imtiyaz Ahmed M. Khazi, Andanappa K. Gadad, Ravi S. Lamani and Bhoomendra A. Bhongade, Chemistry of imidazo[2,1-b][1,3,4]thiadiazoles (Report), Tetrahedron, 2011, 67, 3289-3316.

Book Chapters:

• Afraz Subratti, Nigel K. Jalsa, Bhoomendra Bhongade. Chapter 25, Synthesis of 2,2,2-Trifluoroethyl Glucopyranoside and Mannopyranoside via Classical Fischer Glycosylation. In Kosma P, Wrodnigg TM, Stutz A editors, Carbohydrate Chemistry: Proven Synthetic Methods. Vol 5, Issue 1, CRC Press, Taylor & Francis; 2021, p. 199-206. 
• Areeg Anwer Ali, Bhoomendra A, Bhongade Chapter 31, General Anaesthetics, in Textbook of pharmacology, Bhandari, PR Ed, 1st Edi, Thieme Medical and Scientific Publishers, 2021, p. 238-253. 
• Selected Research Publications: 
• Ashish M. Dhote, Vikas R. Patil, Deepak K. Lokwani, Nikhil D. Amnerkar, Vinod G. Ugale, Nitin B. Charbe, Bhoomendra A. Bhongade, Saurabh C. Khadse. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: In silico molecular docking and dynamic simulation studies. Journal of Biomolecular Structure and  Dynamics,  (2021, Accepted)  DOI: 10.1080/07391102.2021.1965912
• Venkataraman B, Almarzooqi S, Raj V, Dudeja PK, Bhongade BA, Patil RB, Ojha SK, Attoub S, Adrian TE, Subramanya SB. α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study. PPAR Res. 2022, 13;2022:5498115
• Irshad Ahmad, Shagufta, Bong-Sik Kim, Sofia Rahman, Shimy Mathew, Bhoomendra A. Bhongade, Biomass derived adsorbent for the removal of methylene bule dye from wastewater. Indian J. Environmental Protection, 2021, 41(12),1323-1324.
• Al Yazyeh M. S. Alnaqbi, Bhoomendra A. Bhongade, Ahmad Al Azzawi, New Validated Diffuse Reflectance Infrared Fourier Transform Spectroscopic Methodor the Quantification of Levofloxacin in Pharmaceutical Dosage Form. Ind. J. Pharm. Sci., 2021, 83(3), 430-36
• Pooja Sharma, Gurdial Singh, Bhoomendra A. Bhogade, Malleshappa N. Noolvi, Andanappa K. Gadad. Synthesis of 5-fluoroaminobenzothiazoles. SynOpen, 2020, 4, 23-32.  
• Bhoomendra A. Bhongade, Nikhil D. Amnerkar, Andanappa K. Gadad. 3D-QSAR Studies on 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as Plk-1, CDK2/A and Aur-A Serine/Threonine Kinase Inhibitors. Lett. Drug Des. Discov. 2020, 17(4), 386-393.
• Bhoomendra A. Bhongade, Sunil R. Dhaneshwar, Diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) application in pharmaceutical analysis: Method for quantification of ranolozine in Tablet dosage form. Vibrational Spectroscopy, 2017, 93: 52-56.
• Nikhil D. Amnerkar, Bhoomendra A. Bhongade, Kishor P. Bhusari. Synthesis and biological evaluation of some 4-(6-subatituted-1,3-benzothiazole-2-yl)amino-13-thiazole-2-amines and their Schiff bases. Arabian Journal of Chemistry, 2015, 8, 545-552. 
• Bhoomendra A. Bhongade and Andanappa K. Gadad. Insight into the Structural Requirements of Urokinase Plasminogen Activator (uPA) Inhibitors based on 3D-QSAR Models. Journal of Medicinal Chemistry, 2006, 49(2), 475-89. 
• Awards:
• Senior Research Fellowship, Council of Scientific & Industrial Research (CSIR), New Delhi, India (2002-2005)

Research Interests

• Chiral drug (intermediate) synthesis
• Computer aided-drug design, Molecular modelling, 3D-QSAR, Molecular docking.
• Design and synthesis of small molecule as selective inhibitors of enzyme targets involved cancer, microbial and viral infection.  
• Development and validation of FTIR spectroscopic method for the quantification of pharmaceuticals.